🔗 Share this article

The top legal official in Texas Ken Paxton is suing the producers of Tylenol, asserting the firms withheld potential risks that the medication presented to pediatric brain development.

The court filing arrives a month after Donald Trump publicized an unproven link between using acetaminophen - alternatively called acetaminophen - throughout gestation and autism in offspring.

Paxton is taking legal action against the pharmaceutical giant, which previously sold the medication, the exclusive pain medication suggested for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a declaration, he said they "misled consumers by profiting off of discomfort and marketing drugs ignoring the risks."

Kenvue says there is no credible evidence connecting Tylenol to autism spectrum disorder.

"These companies lied for decades, deliberately risking numerous people to line their pockets," Paxton, a Republican, said.

The company stated officially that it was "seriously troubled by the perpetuation of misinformation on the reliability of acetaminophen and the likely effects that could have on the health of US mothers and children."

On its website, the company also mentioned it had "regularly reviewed the relevant science and there is no credible data that shows a verified association between taking acetaminophen and autism."

Organizations speaking for medical professionals and health professionals agree.

The American College of Obstetricians and Gynecologists has declared paracetamol - the primary component in acetaminophen - is a restricted selection for pregnant women to manage discomfort and fever, which can create significant medical dangers if not addressed.

"In over twenty years of research on the consumption of acetaminophen in pregnancy, not a single reputable study has conclusively proven that the usage of acetaminophen in any stage of gestation leads to neurological conditions in young ones," the association said.

This legal action references current declarations from the Trump administration in arguing the drug is potentially dangerous.

Recently, the former president generated worry from public health officials when he told expectant mothers to "struggle intensely" not to consume acetaminophen when unwell.

The FDA then issued a notice that medical professionals should think about restricting the use of Tylenol, while also declaring that "a causal relationship" between the drug and autism in children has not been established.

Health Secretary Kennedy, who supervises the FDA, had vowed in April to conduct "extensive scientific investigation" that would determine the source of autism spectrum disorder in a matter of months.

But experts warned that identifying a unique factor of autism spectrum disorder - thought by researchers to be the outcome of a intricate combination of genetic and external influences - would be difficult.

Autism spectrum disorder is a category of permanent neurological difference and impairment that influences how persons perceive and engage with the world, and is diagnosed using physician assessments.

In his lawsuit, the attorney general - aligned with the former president who is seeking the Senate - alleges Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the evidence" around acetaminophen and autism.

The lawsuit aims to force the firms "destroy any promotional materials" that states Tylenol is secure for pregnant women.

This legal action mirrors the complaints of a assembly of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in two years ago.

A federal judge threw out the case, stating investigations from the family's specialists was not conclusive.